Lynn Schenk, Director at BIOGEN IDEC INC. (BIIB), sold 1,000 shares at $291.71 ($292K) on 2013-12-02, disclosed to the SEC on 2013-12-02.
Scheduled sale ($292k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SRE | SELL | 2014-06-19 | $263K | — | Filing → |
| BIIB | SELL | 2014-01-16 | $297K | — | Filing → |
| BIIB | SELL | 2013-11-05 | $245K | — | Filing → |